KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Equity Average (2016 - 2025)

Johnson & Johnson's Equity Average history spans 17 years, with the latest figure at $78.3 billion for Q2 2025.

  • For Q2 2025, Equity Average rose 10.61% year-over-year to $78.3 billion; the TTM value through Jun 2025 reached $78.3 billion, up 10.61%, while the annual FY2025 figure was $76.5 billion, 9.1% up from the prior year.
  • Equity Average for Q2 2025 was $78.3 billion at Johnson & Johnson, up from $74.8 billion in the prior quarter.
  • Across five years, Equity Average topped out at $78.3 billion in Q2 2025 and bottomed at $63.9 billion in Q1 2021.
  • The 5-year median for Equity Average is $72.1 billion (2022), against an average of $71.9 billion.
  • The largest annual shift saw Equity Average grew 15.2% in 2022 before it decreased 7.53% in 2023.
  • A 5-year view of Equity Average shows it stood at $69.9 billion in 2021, then rose by 7.94% to $75.5 billion in 2022, then fell by 7.26% to $70.0 billion in 2023, then grew by 1.18% to $70.8 billion in 2024, then rose by 10.54% to $78.3 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Equity Average are $78.3 billion (Q2 2025), $74.8 billion (Q1 2025), and $70.8 billion (Q4 2024).